ukmla MCQ (SBA): Diabetic kidney disease therapy

Instant feedback + full explanation. One question, done properly.

MediumNephrologyDiabetic kidney disease therapyukmlamrcgp aktpanemrcem sbamrcp part 1prescribing safety assessment

A 61-year-old woman with CKD stage 3b (eGFR 38) and albuminuria has T2DM. Which drug should be added to reduce progression risk, beyond ACE inhibitor and good BP control?

Educational content. Not a substitute for clinical judgement or local policy.

ukmla MCQ: Diabetic kidney disease therapy — Answer & Explanation | ia